Delic Corp to Present on Strategy and Expansion of Nation's Largest Ketamine Clinic Network at H.C. Wainwright Annual Global Investment Conference
Delic Holdings Corp will showcase its growth strategies at the H.C. Wainwright Annual Global Investment Conference from September 12-14, 2022. Executive Chairman Matt Stang will discuss plans for expanding the clinic footprint and adding more insurance options. The company, which operates the largest network of ketamine clinics in the U.S., aims to enhance access to treatment. A presentation will be available on-demand starting September 12, 2022, at 7 am ET.
- None.
- None.
Matt Stang, executive chairman of Delic, will discuss the company's efforts to grow the clinic footprint, accept a wider selection of insurance options, and its strategic outlook for the remainder of the year
VANCOUVER, BC, Sept. 8, 2022 /PRNewswire/ - Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, confirmed details regarding Delic Corp Executive Chairman Matt Stang's virtual attendance at the 24th annual H.C. Wainwright Annual Global Investment Conference on September 12-14, 2022.
H.C. Wainwright Annual Global Investment Conference
Dates: September 12-14, 2022
Presentation: Available on-demand starting September 12 at 7am ET
The 24th annual conference will explore a wide variety of pertinent topics, including technology, media, life sciences, metals, mining and cryptocurrency. Industry leading innovators and companies will deliver presentations, participate in one-on-one meetings and attend networking events.
During this year's three-day event, Stang will offer a presentation that examines the company's recent growth, the continuing expansion of Ketamine Wellness Centers (KWC), the largest network of ketamine clinics in the U.S., its treatment options, acceptance of various insurance, and efforts to make services more widely available. He will also be available for virtual one-on-one meetings throughout the conference.
For more information regarding the H.C. Wainwright Annual Global Investment Conference, please visit https://hcwevents.com/annualconference/#conference-info.
Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The company owns and operates an umbrella of related businesses, including the largest chain of psychedelic wellness clinics in the country, Ketamine Wellness Centers; the only licensed entity by Health Canada to focus exclusively on research and development of psilocybin vaporization technology, Delic Labs; the premier psychedelic wellness event, Meet Delic; and trusted media and e-commerce platforms Reality Sandwich and Delic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and better access to effective and affordable treatment options.
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Delic's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein may include, but are not limited to: information regarding the timing or terms upon which the Transaction will be completed; potential benefits of the Transaction; anticipated continued growth in the health and wellness sector (and, in particular, related to psychedelics); the ability of Delic to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.
By identifying such information and statements in this manner, Delic is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Delic to be materially different from those expressed or implied by such information and statements. Such risks and other factors may include, but are not limited to: risks and uncertainties relating to the Transaction not closing as planned or at all or on terms and conditions set forth in the Merger Agreement; incorrect assessment of the value and potential benefits of the Transaction; direct and indirect material adverse effects from the COVID-19 pandemic; inability to obtain future financing on suitable terms; failure to obtain required regulatory and other approvals; risks inherent in the psychedelic treatment sector; changes in applicable laws and regulations; and failure to comply with applicable laws and regulations.
In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Delic has made certain assumptions. These assumptions include, but are not limited to: assumptions as to the time required to negotiate a definite agreement and complete matters related to the Transaction; the ability to consummate the Transaction; the ability of the parties to obtain, in a timely manner, the requisite regulatory, corporate and other third party approvals and the satisfaction of other conditions to the consummation of the Transaction on the proposed terms; the potential impact of the announcement or consummation of the Transaction on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time on the Transaction.
Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although Delic believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Delic does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Delic or persons acting on its behalf is expressly qualified in its entirety by this notice.
View original content to download multimedia:https://www.prnewswire.com/news-releases/delic-corp-to-present-on-strategy-and-expansion-of-nations-largest-ketamine-clinic-network-at-hc-wainwright-annual-global-investment-conference-301620334.html
SOURCE Delic Holdings Inc.
FAQ
What will Delic Holdings Corp present at the H.C. Wainwright Annual Global Investment Conference?
When is the H.C. Wainwright Annual Global Investment Conference?
Who is Matt Stang in relation to Delic Holdings Corp?
What is the significance of Ketamine Wellness Centers for Delic Holdings Corp?
What are Delic Holdings Corp's future plans as discussed in the conference?
